Addex Therapeutics Ltd
ADXN
$7.29
$0.41526.04%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.72M | 4.52M | -12.70M | -11.77M | -12.33M |
| Total Depreciation and Amortization | 279.30K | 220.70K | 99.70K | 99.50K | 88.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.69M | -13.20M | 2.37M | 2.52M | 2.80M |
| Change in Net Operating Assets | -28.00K | -351.40K | 1.39M | 275.50K | -1.91M |
| Cash from Operations | -6.72M | -8.81M | -8.83M | -8.87M | -11.36M |
| Capital Expenditure | -2.90K | -2.20K | -5.00K | -7.70K | -6.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.16M | 5.16M | -- | -- | 0.00 |
| Cash from Investing | 5.15M | 5.16M | -5.00K | -7.70K | -6.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -141.00K | -210.90K | -234.50K | -281.80K | -279.70K |
| Issuance of Common Stock | 277.50K | 275.30K | 1.43M | 2.37M | 2.35M |
| Repurchase of Common Stock | -29.00K | -49.40K | -43.40K | -50.10K | -75.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -59.20K | -155.20K | 3.25M | 3.22M | 3.16M |
| Cash from Financing | 58.20K | -155.10K | 4.90M | 5.82M | 5.71M |
| Foreign Exchange rate Adjustments | -157.70K | -88.50K | -256.10K | -399.20K | -400.30K |
| Miscellaneous Cash Flow Adjustments | -11.60K | -11.60K | -349.80K | -- | -- |
| Net Change in Cash | -1.68M | -3.91M | -4.55M | -3.46M | -6.06M |
